The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

S.B. Shappell

Department of Pathology

Division of Clinical Pharmacology

Vanderbilt University School of Medicine

Nashville

USA

[email]@*.vanderbilt.edu

Name/email consistency: high

[Claim this account]

Affiliations

Department of Pathology, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, USA. 1999 - 2001
Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2561, USA. 2001

References

15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Shappell, S.B., Gupta, R.A., Manning, S., Whitehead, R., Boeglin, W.E., Schneider, C., Case, T., Price, J., Jack, G.S., Wheeler, T.M., Matusik, R.J., Brash, A.R., Dubois, R.N. Cancer Res. (2001) [Pubmed]
Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. Shappell, S.B., Manning, S., Boeglin, W.E., Guan, Y.F., Roberts, R.L., Davis, L., Olson, S.J., Jack, G.S., Coffey, C.S., Wheeler, T.M., Breyer, M.D., Brash, A.R. Neoplasia (2001) [Pubmed]
15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Shappell, S.B., Boeglin, W.E., Olson, S.J., Kasper, S., Brash, A.R. Am. J. Pathol. (1999) [Pubmed]